Abstract: The invention relates to a bogie (1) for a guideway-bound levitation vehicle (7) of a magnetic levitation system, with two rows (21, 22) of multiple levitation frames (2) spaced apart from each other in a transverse direction (Y) of the bogie (1) and extending in a longitudinal direction (X) of the bogie (1), with at least two cross members (3) spaced apart from each other in the longitudinal direction (X) and extending in the transverse direction (Y) and connecting the two rows (21, 22) of multiple levitation frames (2) to each other, with at least one longitudinal member (4) extending in the longitudinal direction (X) and connected to the cross members (3), and with at least one receiving means (18) for receiving a vehicle compartment (8) of the levitation vehicle (7).

Abstract: The invention relates to a levitation frame (7) for a vehicle (2) of a magnetic levitation railway (1) having a magnet unit (8) for the electromagnetic lateral guidance of the vehicle (2), and having a mechanical side guide (11). Furthermore, the invention relates to a vehicle (2) for a magnetic levitation railway (1) having at least one levitation chassis (6), wherein the levitation chassis (6) has at least one levitation frame (7). In addition, the invention relates to rail system (3) of a magnetic levitation railway (1) having a track (4) which is designed to at least partially enclose a levitation chassis (6) of a vehicle (2). Finally, the invention relates to a magnetic levitation railway (1) having a vehicle (2) and a rail system (3). For the levitation frame (7) it is proposed that the mechanical side guide (11) has a guide element (13) and at least one joint (14), wherein the guide element (13) is movably connected to the levitation frame (7) via the joint (14).

Abstract: A powder inhaler for administering powder by inhalation, comprising: a flow path defined by a plurality of surfaces through which a stream of air is in use drawn on inhalation by a user; and dosing means (18) for providing a dose of powder to the flow path for entrainment in the stream of air; characterized in that the inhaler further comprises dislodging means for dislodging powder accumulated on a surface of the flow path downstream of the dosing means (18).

Abstract: A powder inhaler for administering powder by inhalation, comprising: a flow path defined by a plurality of surfaces through which a stream of air is in use drawn on inhalation by a user; and dosing means (18) for providing a dose of powder to the flow path for entrainment in the stream of air; characterized in that the inhaler further comprises dislodging means for dislodging powder accumulated on a surface of the flow path downstream of the dosing means (18).

Abstract: A powder inhaler for administering powder by inhalation, comprising: a flow path defined by a plurality of surfaces through which a stream of air is in use drawn on inhalation by a user; and dosing means (18) for providing a dose of powder to the flow path for entrainment in the stream of air; characterized in that the inhaler further comprises dislodging means for dislodging powder accumulated on a surface of the flow path downstream of the dosing means (18).

Abstract: A powder inhaler for administering powder by inhalation, comprising: a flow path defined by a plurality of surfaces through which a stream of air is in use drawn on inhalation by a user; and dosing means (18) for providing a dose of powder to the flow path for entrainment in the stream of air; characterized in that the inhaler further comprises dislodging means for dislodging powder accumulated on a surface of the flow path downstream of the dosing means (18).

Abstract: A powder inhaler for administering powder by inhalation, comprising: a flow path defined by a plurality of surfaces through which a stream of air is in use drawn on inhalation by a user; and dosing means (18) for providing a dose of powder to the flow path for entertainment in the stream of air; characterized in that the inhaler further comprises dislodging means for dislodging powder accumulated on a surface of the flow path downstream of the dosing means (18).

Abstract: The invention provides a pharmaceutical composition for rectal or vaginal administration which comprises at least two parts wherein the composition comprises (i) two or more physiologically acceptable substances each in separate parts of the composition which are such that on admixture they react to produce a physiologically acceptable gas; (ii) in at least one part of the composition a polymer stabiliser which is adapted to facilitate the formation of a water-soluble collapsible foam structure; and (iii) in at least one part of the composition a pharmaceutically active substance; an its use in the treatment or prophylaxis of disorders of the intestines, rectum or vagina.

Abstract: The invention provides a unit formulation which comprises a 2-hydroxy-5-phenylazobenzoic acid derivative which is particularly sodium balsalazide dihydrate which formulation has a density of at least 0.9 mg/mm3 and its use in the treatment of gastrointestinal diseases.

Abstract: Cholestyramine and starch containing, oil-free compositions with excellent organoleptic features are obtained by mixing cholestyramine and grain starch in a weight ratio of 1:1.8 to 2.9 with the addition of grain bran as a filler and optionally an aroma stuff with 10 to 35% by weight of water (calc. on the starting materials) into a homogenous moist mass, forming of the mass through extrusion into a string, whereby the temperature is 105.degree.-180.degree. C. (measured in the mass in the extrusion head) and the pressure is 30-70 bars (measured in the extrusion head), and subsequently drying at a temperature above 100.degree. C. to a remaining humidity of .ltoreq.3.5% by weight, whereby the extruded material before or after the drying is divided into bars or is grinded into a powder.